We are live on
!
Find out more
VBIV
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
VBIV
Delisted
VBIV was delisted on the 7th of August, 2024.
39 hedge funds and large institutions have $1.73M invested in VBI Vaccines, Inc. New Common Stock (Canada) in 2023 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 6 increasing their positions, 9 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
53,100% more call options, than puts
Call options by funds: $532K | Put options by funds: $1K
50% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 4
5% more funds holding
Funds holding: 37 → 39 (+2)
9% less capital invested
Capital invested by funds: $1.9M → $1.73M (-$175K)
33% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 9
Holders
39
Holders Change
+2
Holders Change %
+5.41%
% of All Funds
0.57%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
6
Reduced
9
Closed
4
Calls
$532K
Puts
$1K
Net Calls
+$531K
Net Calls Change
-$139K
Top Buyers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$72.2K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$43.6K |
| 3 |
Renaissance Technologies
New York
|
+$23.8K |
| 4 |
Goldman Sachs
New York
|
+$18.3K |
| 5 |
Morgan Stanley
New York
|
+$17.5K |
Top Sellers
| 1 |
Alyeska Investment Group
Chicago,
Illinois
|
-$42.3K |
| 2 |
GAI
General American Investors
New York
|
-$41.7K |
| 3 |
Millennium Management
New York
|
-$29.7K |
| 4 |
HF
HRT Financial
New York
|
-$15K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$8.16K |
